Taken together, these findings indicate that BTZ-resistant MM cells are still sensitive to HDAC6 inhibitors and that both BTZ-sensitive and BTZ-resistant U266 cells are more sensitive to A452 than ACY-1215. The gene discussed is CASC3; the disease is Miyoshi myopathy.